A Day Up For Cyclerion Therapeutics, Inc.
Wed, Dec 04, 2024 at 07:30 PM
Cyclerion Therapeutics, Inc. (CYCN:NASDAQ) jumped higher at $6.35, a gain of 294.4%. On Wed, Dec 04, 2024, CYCN:NASDAQ hit a New 2-Week High of $6.35. The stock got featured on our News Catalysts scanner on Fri, Nov 08, 2024 at 08:22 PM in the 'EARNINGS' category. From Wed, Nov 20, 2024, the stock recorded 66.67% Up Days and 60.00% Green Days
The stock spiked on Wed, Dec 04, 2024 at $9.47 with a volume of 140M+.
About Cyclerion Therapeutics, Inc. (CYCN:NASDAQ)
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases.Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators.
Top 10 Gainers:
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 294.41%
- bluebird bio, Inc. (BLUE:NASDAQ), 105.38%
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 105.34%
- SRM Entertainment Inc. (SRM:NASDAQ), 84.1%
- Cross Country Healthcare, Inc. (CCRN:NASDAQ), 62.72%
- CN Energy Group Inc. (CNEY:NASDAQ), 61.68%
- Power REIT (PW:NYSEMKT), 51.72%
- Perfect Moment Ltd. (PMNT:NYSEMKT), 46.75%
- Snail, Inc. (SNAL:NASDAQ), 46.67%
- Reitar Logtech Holdings Limited (RITR:NASDAQ), 41.42%